SecBot SecBot
PRESS-RELEASE ·Filed Nov 5, 2026

IRTC

iRhythm
BULLISH
Impact 6/10
Horizonweeks Processed11d 10h ago WireGlobeNewswire
Press release · Earnings
Actionable Insight ▲ Bullish

The massive adjusted EPS beat and raised guidance are the headline positives, but the slight revenue miss and the GAAP net loss widening due to $49.8M in litigation settlements warrant monitoring. The VitalConnect acquisition adds MCT capabilities and $16M of expected revenue in FY2026; integration execution and margin trajectory will be key to sustaining the momentum.

DirectionBullish
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$90.22
T+0 close · Nov 5, 2026 · via day close
Latest settled
+1.87%
T+5 · $91.91 · next T+20 in 20d
Vs SPY
−0.72%
α at T+5
Latest observation
+1.57%
T+6 · FF3 residual α
  1. T+0 · Nov 6 $90.22entry
  2. T+1 · 8d ago −1.65%α −4.02% · $88.73
  3. T+5 · 4d ago +1.87%α −0.72% · $91.91
  4. T+6 · todayOpen
  5. T+20 · in 20d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

iRhythm reported Q3 2026 revenue of $221.6M, up 14.9% YoY and slightly below the $222.2M consensus. Adjusted EPS of $0.82 far exceeded the $0.05 consensus, driven by strong margin expansion and operating leverage. The company raised full-year 2026 revenue guidance to $890M-$895M and adjusted EBITDA margin guidance to 15.5%-16.0%, and closed the VitalConnect acquisition on October 5, 2026.

Key Financial Metrics

EPS (Adj.)
$0.82
est $0.05 · +1540.0% · GAAP: $-0.90
Revenue
$221.6M
est $222.2M · -0.3% · +14.9% YoY
Rating
beat
Guidance
$890M-$895M
raised
Free Cash Flow
-$11.5M
Gross Margin
74.2%

Key Facts

  • Q3 2026 revenue $221.6M, up 14.9% YoY from $192.9M
  • Adjusted EPS $0.82 vs consensus $0.05 (beat by $0.77 or +1540%)
  • GAAP net loss $29.9M ($0.90 loss per share) vs $5.2M loss ($0.16 loss) in Q3 2025
  • Gross margin 74.2%, up 310 bps YoY
  • Adjusted EBITDA $51.2M (23.1% margin), up from $21.6M (11.2% margin) in Q3 2025
  • Raised FY2026 revenue guidance to $890M-$895M (from prior range not stated) and adjusted EBITDA margin guidance to 15.5%-16.0%
  • Closed VitalConnect acquisition on October 5, 2026
  • Closed new $300M senior secured revolving credit facility on November 3, 2026
  • Unrestricted cash, cash equivalents and marketable securities $560.7M as of September 30, 2026

Financial Impact

Adjusted EPS of $0.82 vs $0.05 consensus represents a $0.77 beat; revenue $221.6M vs $222.2M consensus was a slight miss of $0.6M. Raised guidance implies full-year revenue midpoint of $892.5M, up from prior guidance not disclosed.

revenueadjusted EPSadjusted EBITDA margingross margin

Risk Factors

  • Revenue slightly below consensus ($221.6M vs $222.2M) despite strong volume growth
  • GAAP net loss widened to $29.9M from $5.2M in Q3 2025, driven by $49.8M in litigation settlements
  • Free cash flow negative $11.5M in Q3 2026 vs positive $20.1M in Q3 2025, partly due to $50M in litigation settlement payments
  • VitalConnect acquisition integration risk and potential dilution from the $300M credit facility

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
95% bullish (22 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3397028

Track record

31 reports on IRTC

Performance horizon

7 of 10 bullish or bearish reports moved the stock their way by T+5. Best: +16.85% at T+60 after the Feb 25, 2026 report. 9 of 10 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $90.12 Now $90.83 +0.79% settles Nov 23
  2. Nov 13, 20263d ago 8-K Neutral 2/10 Entry $91.91 Now $90.83 −1.18% settles Nov 20
  3. Nov 12, 20264d ago SC 13G/A Neutral 3/10 Entry $93.56 Now $90.83 −2.92% settles Nov 19
  4. Nov 12, 20264d ago 8-K Neutral 4/10 Entry $93.56 Now $90.83 −2.92% settles Nov 19
  5. Nov 11, 20265d ago Press Release Neutral 3/10 Entry $93.56 Now $90.83 −2.92% settles Nov 19
  6. Nov 5, 202611d ago 8-K Mixed 6/10 No price data
  7. Nov 5, 202611d ago Press Release Bullish 6/10 Viewing Entry $90.22 to $91.91 Now $90.83 +0.68% ▲ +1.87% −0.72% vs SPY
  8. Oct 27, 202620d ago Institutional Cluster Mixed 4/10 Entry $123.99 to $134.00 Now $90.83 −26.74% ▲ +8.07% +8.79% vs SPY
  9. Oct 15, 20264w ago Press Release Neutral 1/10 Entry $108.66 Now $90.83 −16.41% No price data
  10. Oct 13, 20264w ago SC 13G/A Neutral 2/10 Entry $106.05 to $113.55 Now $90.83 −14.35% ▲ +7.07% +6.62% vs SPY
Showing 10 of 31

US Market Status

Market Closed · Opens in 6h 26m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 5, 2026